Indeed, we observed that CXCL10 further increased when KTRs with BKPyV DNAemia subsequently developed allograft rejection, but considering that CXCL10 responses might vary among individuals, it seems questionable whether quantitative differences might ultimately discriminate between PVAN and rejection. This evidence concerns the gene CXCL10 and BK-virus nephropathy.